Send feedback

NPC1 p.Pro237Ser

c.709C>T · rs80358251 · VCV21142

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 15 submitters
AlphaMissense
likely benign
0.1037 · ACMG-weighted
gnomAD v4.1
Rare
low-frequency (popmax 1.61%, nfe)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
2
nasopharyngeal carcinoma

Computational evidence

Protein change
AlphaMissense0.1037likely benign
REVEL0.398indeterminate
SaProtLLR -9.52tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 1.8, phastCons 1
Regional constrainto/e 0.93unconstrained · MANE · 54 kb · p 0.0029 · regional, not allelic
Overall
CADD21.2PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 1.61% European (non-Finnish) · 19,049/1,179,998 alleles
Filtering AF 1.6% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.59%
Overall 1.34% 21,697/1,614,168 alleles · low-frequency exomes 20,169/1,461,824 · genomes 1,528/152,344 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 1.96% 51
European (non-Finnish)grpmax 1.61% 62
Remaining individualsnot grpmax-eligible 1.18% 85
Admixed American 0.453% 221
Ashkenazi Jewishnot grpmax-eligible 0.331% 302
African / African-American 0.248% 404
Middle Eastern 0.165% 605
South Asian 0.102% 979
East Asian 0.00223% 44,886

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
NPC1
Protein
p.Pro237Ser
Coding
c.709C>T
MANE Select
NM_000271
dbSNP
rs80358251
Type
single nucleotide variant
Location
chr18:23560403 (GRCh38)
Gene constraint
LOEUF 0.676 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 85.35 · 20 PDB
Residue 237
an α-helix; a UniProt-annotated variant site (no effect on function; colocalizes with the wild-type protein with rab7-positive late endosomes; clears the lysosomal cholesterol accumulation in npc1-deficient cells)
Full NPC1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

nasopharyngeal carcinoma — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: Niemann-Pick disease, type C1

For Nasopharyngeal carcinoma (Orphanet):

Inheritance
Multigenic/multifactorial, Not applicable
Onset
All ages
Prevalence
1-9 / 1 000 000 (China)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/npc1-p-pro237ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown